LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...
Advancing brain microphysiological systems for in vitro neurotoxicity and cognitive function testing
In a recent webinar, Dr. Lena Smirnova explained how brain microphysiological systems are transforming in vitro neurotoxicity testing and disease modeling. NewsMedical compiled the key highlights in ...
Non-Alcoholic Fatty Liver Disease (NAFLD) Affects 30-40% of U.S. Adults, Driving Significant Market Need for BioHarvest's Future Olive Cell Product Targeting Liver Health Vancouver, British Columbia ...
Small variations in formulation can affect bioequivalence. However, with simultaneous dissolution-permeation testing, true absorption potential is revealed. Image Credit: Mentor57/Shutterstock.com ...
Recent years have seen a growing movement away from animal testing and toward models that more closely replicate human physiology. This shift aims to protect animal welfare while concurrently ...
Please provide your email address to receive an email when new articles are posted on . The FDA announced plans in 2025 to reduce animal testing requirements in biomedical research. New approach ...
Etelka is a post-doctoral research fellow exploring aerosol science with biology and engineering.View full profile Etelka is a post-doctoral research fellow exploring aerosol science with biology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results